Dr. Melanie Tomczak | Chief Technology Officer BioMADE We are pleased to announce that BioMADE has selected Dr. Melanie Tomczak, Director of Biological and Nanoscale Technologies at UES, Inc., to serve as its first permanent Chief Technology Officer. As CTO, Dr. Tomczak will develop, support, and oversee BioMADE technical priorities; drive strategic decisions on bioindustrial manufacturing technology; and manage a programmatic budget to catalyze innovation and manufacturing capability nationally. Dr. Tomczak comes to BioMADE from UES, which she joined in 2004 as a Research Scientist and Program Manager. She was then named Director of Biological and Nanoscale Technologies at the division’s inception in 2010. During her tenure at UES, she grew the “bio group” from 5 to 95 employees by repeatedly winning competitive Air Force Research Laboratory on-site contracts and being awarded more than 15 Small Business Innovation Research grants from agencies including NIH, USDA, EPA, DTRA, DARPA, and Army. A leader in the field, Dr. Tomczak was a founding governing council member of the Nano Bio Manufacturing Consortium (NBMC) and served as Co-Chair of the Technical Working Group. Prior to joining UES, Dr. Tomczak was a postdoctoral fellow in Biochemistry at Queen’s University, Canada. She holds a Ph.D. in Plant Biology from the University of California – Davis, where she was an NSF-sponsored Plant Cell Biology Trainee, and a B.S. from the University of Illinois at Urbana-Champaign, where she was both a Hugh Morrison Scholar and a Jonathan Baldwin Turner Scholar. Her scientific expertise is in biotechnology, biochemistry, biosensor development, protein structure-function relationships, and co-opting what nature does well. Andy Lee led this search with Keith Mason.